Charles Cherington 13D and 13G filings for Comera Life Sciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-05 7:16 pm Purchase |
2023-12-27 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 45,989,871 66.310% |
32,000,317 (+228.74%) |
Filing |
| 2023-09-07 8:05 pm Purchase |
2023-08-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 13,989,554 37.450% |
8,568,949 (+158.08%) |
Filing |
| 2023-08-25 8:40 pm Purchase |
2023-07-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 5,420,605 19.990% |
986,195 (+22.24%) |
Filing |
| 2023-01-06 4:36 pm Purchase |
2023-01-02 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 4,434,410 18.700% |
2,304,636 (+108.21%) |
Filing |
| 2022-09-13 09:42 am Purchase |
2022-05-19 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 2,129,774 11.200% |
2,129,774 (New Position) |
Filing |